martes, 4 de agosto de 2020

Cancer drug is first therapy to emerge from 23andMe-GSK deal - STAT

Cancer drug is first therapy to emerge from 23andMe-GSK deal - STAT

Cancer Briefing

STAT Plus: Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration

By MATTHEW HERPER


ADOBE
GlaxoSmithKline is starting human trials of the first medicine, a cancer drug, to emerge from its collaboration with consumer genetics firm 23andMe.

No hay comentarios: